 LONG BEACH, Calif.--BUSINESS WIRE--The Beauty Health Company BeautyHealth or the Company; NASDAQ:SKIN today announced the pricing of its offering of 650,000,000 aggregate principal amount of 1.25 convertible senior notes due 2026 the notes in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended the Securities Act. The offering size was increased from the previously announced of 